NZ617191A - Swine influenza hemagglutinin variants - Google Patents
Swine influenza hemagglutinin variantsInfo
- Publication number
- NZ617191A NZ617191A NZ617191A NZ61719110A NZ617191A NZ 617191 A NZ617191 A NZ 617191A NZ 617191 A NZ617191 A NZ 617191A NZ 61719110 A NZ61719110 A NZ 61719110A NZ 617191 A NZ617191 A NZ 617191A
- Authority
- NZ
- New Zealand
- Prior art keywords
- influenza hemagglutinin
- swine influenza
- variants
- hemagglutinin variants
- following
- Prior art date
Links
- 206010069767 H1N1 influenza Diseases 0.000 title abstract 2
- 101710154606 Hemagglutinin Proteins 0.000 title abstract 2
- 208000009620 Orthomyxoviridae Infections Diseases 0.000 title abstract 2
- 101710093908 Outer capsid protein VP4 Proteins 0.000 title abstract 2
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 title abstract 2
- 101710176177 Protein A56 Proteins 0.000 title abstract 2
- 239000000185 hemagglutinin Substances 0.000 title abstract 2
- 201000010740 swine influenza Diseases 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16171—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22042609P | 2009-06-25 | 2009-06-25 | |
| US22798609P | 2009-07-23 | 2009-07-23 | |
| US23402109P | 2009-08-14 | 2009-08-14 | |
| US25889009P | 2009-11-06 | 2009-11-06 | |
| NZ596823A NZ596823A (en) | 2009-06-25 | 2010-06-24 | Swine influenza hemagglutinin variants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ617191A true NZ617191A (en) | 2015-06-26 |
Family
ID=43386887
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ617191A NZ617191A (en) | 2009-06-25 | 2010-06-24 | Swine influenza hemagglutinin variants |
| NZ596823A NZ596823A (en) | 2009-06-25 | 2010-06-24 | Swine influenza hemagglutinin variants |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ596823A NZ596823A (en) | 2009-06-25 | 2010-06-24 | Swine influenza hemagglutinin variants |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8088393B2 (OSRAM) |
| EP (1) | EP2448598B1 (OSRAM) |
| JP (1) | JP5745511B2 (OSRAM) |
| KR (1) | KR20120101318A (OSRAM) |
| CN (1) | CN102802666B (OSRAM) |
| AU (2) | AU2010266078B2 (OSRAM) |
| BR (1) | BRPI1014844A2 (OSRAM) |
| CA (1) | CA2766377A1 (OSRAM) |
| MX (1) | MX2012000123A (OSRAM) |
| NZ (2) | NZ617191A (OSRAM) |
| RU (1) | RU2560420C2 (OSRAM) |
| SG (2) | SG176178A1 (OSRAM) |
| WO (1) | WO2010151673A1 (OSRAM) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2560420C2 (ru) | 2009-06-25 | 2015-08-20 | МЕДИММЬЮН, ЭлЭлСи | Варианты гемагглютининов вируса свиного гриппа |
| EP2764015A1 (en) * | 2011-10-07 | 2014-08-13 | Medlmmune, LLC | Influenza hemagglutinin variants |
| KR101315273B1 (ko) * | 2012-10-29 | 2013-10-08 | 대한민국 | 강독화된 인플루엔자 바이러스 변이주 |
| US9708585B2 (en) * | 2012-12-03 | 2017-07-18 | Seqirus UK Limited | Influenza virus reassortment |
| JP6974943B2 (ja) * | 2014-05-13 | 2021-12-01 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | ２種の抗体構築物を発現するａａｖを含む組成物およびこの使用 |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11535665B2 (en) | 2015-05-13 | 2022-12-27 | The Trustees Of The University Of Pennsylvania | AAV-mediated expression of anti-influenza antibodies and methods of use thereof |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| JOP20190200A1 (ar) | 2017-02-28 | 2019-08-27 | Univ Pennsylvania | تركيبات نافعة في معالجة ضمور العضل النخاعي |
| WO2018160573A1 (en) | 2017-02-28 | 2018-09-07 | The Trustees Of The University Of Pennsylvania | Influenza vaccines based on aav vectors |
| WO2018160582A1 (en) | 2017-02-28 | 2018-09-07 | The Trustees Of The University Of Pennsylvania | Adeno-associated virus (aav) clade f vector and uses therefor |
| CN111511397A (zh) | 2017-12-22 | 2020-08-07 | 科达金尼克斯有限公司 | 具有密码子对去优化区域的重组病毒及其用于治疗癌症的用途 |
| CN112040977A (zh) | 2018-03-08 | 2020-12-04 | 科达金尼克斯有限公司 | 减毒黄病毒 |
| WO2025081053A1 (en) * | 2023-10-11 | 2025-04-17 | Flugen, Inc. | Formulations for thermostable vaccines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7871626B2 (en) * | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
| US8354114B2 (en) * | 2005-10-17 | 2013-01-15 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
| AU2007286161B2 (en) * | 2006-08-09 | 2013-05-02 | Medimmune, Llc | Influenza hemagglutinin and neuraminidase variants |
| MX2009013008A (es) * | 2007-05-31 | 2010-06-09 | Vacunas para la influenza. | |
| RU2560420C2 (ru) | 2009-06-25 | 2015-08-20 | МЕДИММЬЮН, ЭлЭлСи | Варианты гемагглютининов вируса свиного гриппа |
-
2010
- 2010-06-24 RU RU2012102385/10A patent/RU2560420C2/ru not_active IP Right Cessation
- 2010-06-24 MX MX2012000123A patent/MX2012000123A/es not_active Application Discontinuation
- 2010-06-24 BR BRPI1014844A patent/BRPI1014844A2/pt not_active IP Right Cessation
- 2010-06-24 EP EP10792667.7A patent/EP2448598B1/en not_active Not-in-force
- 2010-06-24 NZ NZ617191A patent/NZ617191A/en not_active IP Right Cessation
- 2010-06-24 NZ NZ596823A patent/NZ596823A/xx not_active IP Right Cessation
- 2010-06-24 CA CA2766377A patent/CA2766377A1/en not_active Abandoned
- 2010-06-24 KR KR1020127000803A patent/KR20120101318A/ko not_active Ceased
- 2010-06-24 WO PCT/US2010/039826 patent/WO2010151673A1/en not_active Ceased
- 2010-06-24 US US12/822,781 patent/US8088393B2/en not_active Expired - Fee Related
- 2010-06-24 CN CN201080027726.4A patent/CN102802666B/zh not_active Expired - Fee Related
- 2010-06-24 AU AU2010266078A patent/AU2010266078B2/en not_active Ceased
- 2010-06-24 JP JP2012517731A patent/JP5745511B2/ja not_active Expired - Fee Related
- 2010-06-24 SG SG2011085669A patent/SG176178A1/en unknown
- 2010-06-24 SG SG10201403557QA patent/SG10201403557QA/en unknown
-
2011
- 2011-12-01 US US13/308,809 patent/US8715691B2/en not_active Expired - Fee Related
-
2014
- 2014-06-25 AU AU2014203458A patent/AU2014203458A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2448598A1 (en) | 2012-05-09 |
| US8715691B2 (en) | 2014-05-06 |
| WO2010151673A1 (en) | 2010-12-29 |
| SG176178A1 (en) | 2011-12-29 |
| CA2766377A1 (en) | 2010-12-29 |
| RU2012102385A (ru) | 2013-07-27 |
| JP5745511B2 (ja) | 2015-07-08 |
| US20120244600A1 (en) | 2012-09-27 |
| US8088393B2 (en) | 2012-01-03 |
| EP2448598B1 (en) | 2016-03-30 |
| BRPI1014844A2 (pt) | 2019-09-24 |
| CN102802666B (zh) | 2015-06-03 |
| JP2012531205A (ja) | 2012-12-10 |
| EP2448598A4 (en) | 2013-10-23 |
| AU2010266078A1 (en) | 2011-12-22 |
| SG10201403557QA (en) | 2014-10-30 |
| RU2560420C2 (ru) | 2015-08-20 |
| AU2010266078B2 (en) | 2014-08-14 |
| NZ596823A (en) | 2013-11-29 |
| AU2014203458A1 (en) | 2014-07-17 |
| KR20120101318A (ko) | 2012-09-13 |
| US20110123559A1 (en) | 2011-05-26 |
| CN102802666A (zh) | 2012-11-28 |
| MX2012000123A (es) | 2012-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ617191A (en) | Swine influenza hemagglutinin variants | |
| BR112012014082A2 (pt) | composições e métodos que compreendem variantes de protease | |
| MX2010001284A (es) | Vacunas contra la influenza con multiepitope multimerico. | |
| IN2014CN02114A (OSRAM) | ||
| MX2011000437A (es) | Variantes de hemaglutinina y neuramnidasa de influenza. | |
| MX2012003185A (es) | Composiciones farmaceuticas que comprenden bi-1356 y metformina. | |
| MX2013015311A (es) | Polipeptidos de enlace de pcsk9 y metodos de uso. | |
| TWI370135B (en) | Analogs of ghrelin substituted at the n-terminal | |
| IL213189A0 (en) | Recombinant avian influenza vaccine and uses thereof | |
| IN2015MN00027A (OSRAM) | ||
| EP2671429A1 (de) | Ansteuerung von leuchtmitteln über deren ac-versorgungsspannung | |
| ZA201402939B (en) | Tyrosine Based Linkers for the Releasable Connection of Peptides | |
| EP2632941A4 (en) | RECOMBINANT HEMAGGLUTININE PROTEIN OF THE INFLUENZA VIRUS AND VACCINE THEREWITH | |
| MY165088A (en) | Pharmaceutical compositions comprising alisporivir | |
| IT1397023B1 (it) | Composizioni comprendenti amminoacidi, per il trattamento della broncopneumopatia cronica ostruttiva | |
| PL2555790T3 (pl) | ZASTOSOWANIE LECZNICZE ß2-MIKROGLOBULINY | |
| MX2010011055A (es) | Derivados peptidicos de opiorfina como potentes inhibidores de ectopeptidasas degradadoras de encefalinas. | |
| AU331434S (en) | Chair base cover | |
| GB201019467D0 (en) | Therapeutic agent | |
| IN2012DN04805A (OSRAM) | ||
| UA41922U (ru) | Применение альтана как вещества с противолучевыми свойствами | |
| AU325765S (en) | Leg | |
| ITRM20110155U1 (it) | Bruciatore atmosferico multigas specifico per l'alimentazione dei forni tradizionali e meccanici | |
| AU310844S (en) | Flag pole | |
| UA44815U (ru) | МОДИФИЦИРОВАННЫЙ ГЕННО-ИНЖЕНЕРНЫЙ РЕКОМБИНАНТНЫЙ БЕЛОК rExhCD34, ПРОДУЦИРОВАННЫЙ БАКТЕРИЯМИ e. COLI |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| LAPS | Patent lapsed |